Home Cart Sign in  
Chemical Structure| 1041434-82-5 Chemical Structure| 1041434-82-5

Structure of Peramivir Trihydrate
CAS No.: 1041434-82-5

Chemical Structure| 1041434-82-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Peramivir Trihydrate is a novel cyclopentane neuraminidase inhibitor of influenza virus, used to treat acute symptomatic influenza A and B.

Synonyms: RWJ 270201 trihydrate; BCX 1812 trihydrate; S-021812

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Peramivir Trihydrate

CAS No. :1041434-82-5
Formula : C15H34N4O7
M.W : 382.45
SMILES Code : O=C([C@@H]1[C@@H](O)[C@@H]([C@@H](NC(C)=O)C(CC)CC)[C@H](NC(N)=N)C1)O.[H]O[H].[H]O[H].[H]O[H]
Synonyms :
RWJ 270201 trihydrate; BCX 1812 trihydrate; S-021812
MDL No. :MFCD22417093
InChI Key :RFUCJKFZFXNIGB-ZBBHRWOZSA-N
Pubchem ID :11954371

Safety of Peramivir Trihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDCK-hPEPT1 cells 0.5 mM 10 min Evaluate the uptake of Peramivir-(CH2)2-l-Val and Peramivir-l-Ile in MDCK-hPEPT1 cells, results showed that the uptake of these two prodrugs was significantly higher than in mock cells and could be inhibited by gly-sar, indicating their uptake is mediated by PEPT1. PMC7032255
Caco-2 cells 0.5 mM 120 min Evaluate the permeability of Peramivir and its prodrugs in Caco-2 cells, results showed that all prodrugs had higher permeability than Peramivir, with Peramivir-(CH2)2-l-Val and Peramivir-l-Ile showing the highest permeability. PMC7032255
Human Peripheral Blood Mononuclear Cells (hPBMCs) 2.5, 5, 10 μM 6 or 12 h To evaluate the inhibitory effect of Peramivir on TNF-α, results showed that Peramivir significantly inhibited TNF-α release at 6 h and 12 h in a time- and dose-dependent manner. PMC8918788
Macrophages 10 µM 4 h To evaluate the inhibitory effect of Peramivir on TNF-α, results showed that Peramivir inhibited TNF-α release by 67.2% at 10 µM. PMC8918788

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice LPS-induced cytokine storm model Intraperitoneal injection 20 mg/kg, 60 mg/kg Single injection To evaluate the inhibitory effect of Peramivir on cytokine storm, results showed that Peramivir significantly reduced multiple cytokines in serum and bronchoalveolar lavage fluid (BALF), alleviated acute lung injury, and prolonged the survival time of mice. PMC8918788

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.07mL

2.61mL

1.31mL

26.15mL

5.23mL

2.61mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories